Latest medical research news and updates from Switzerland. AI-curated articles covering medical research topics.
Swiss pharmaceutical giant announces positive results from phase III trials combining giredestrant and everolimus treatments, showing significant improvement in patient survival rates.
Swiss pharmaceutical giant announces significant progress in phase III clinical trials combining giredestrant and everolimus treatments
EPFL and Lausanne University Hospital researchers develop groundbreaking implant to address chronic hypotension in spinal cord injury patients.
Lausanne researchers develop revolutionary implant to address chronic hypotension in spinal cord injury patients, marking significant advancement in neuroscience.
Swiss Sepsis Programme reveals alarming death toll from sepsis matches combined fatalities from strokes and heart attacks, calling for increased awareness and intervention.
Swiss researchers discover mechanism by which cancer cells manipulate neighboring healthy cells through mitochondrial transfer, opening new therapeutic possibilities.
National Cancer Registry study reveals Switzerland maintained cancer survival rates during COVID-19, unlike other countries.
Swiss pharmaceutical giant Novartis reports successful Phase III trials for Ianalumab therapy, potentially offering the first targeted treatment for Sjögren's Syndrome patients worldwide.
One year after establishing Switzerland's first gender medicine professorship, the University of Zurich reports successful implementation despite initial challenges.
Swiss pharmaceutical giant secures CE mark for innovative chest pain triage algorithm, advancing emergency cardiac care diagnostics across Europe.
Swiss pharmaceutical leader Roche receives European certification for innovative AI-powered triage system to help emergency departments identify heart attack risks more efficiently.
Lausanne researchers combine rehabilitation robots with spinal implants in innovative treatment showing promising results for patients with spinal cord injuries.
University of Geneva researchers identify crucial lipid changes that could predict chemotherapy resistance in colorectal cancer patients, potentially revolutionizing treatment approaches.
Bern's Inselspital keeps donor heart viable for 12 hours using revolutionary ex vivo perfusion technique, doubling transplant success rates
University of Geneva researchers uncover bacterial toxin mechanism that could revolutionize targeted cancer treatment delivery.
ETH Zurich researchers develop first detailed cellular map showing why some overweight individuals develop metabolic diseases while others remain healthy.
University of Geneva researchers discover new mechanism for targeted drug delivery, potentially revolutionizing cancer treatment methods.
New Swiss study shows women have significantly lower survival rates after cardiac arrest and receive less intensive care than men.
New study reveals women in Switzerland have significantly lower survival rates from cardiac arrest and receive less intensive care than men
CHUV becomes Switzerland's first hospital approved to produce medication from fecal bacteria, marking a breakthrough in treating severe intestinal infections.
From trusted Swiss news outlets